Drugs Manufactured With A Forged License, FIR Lodged, Drugs Worth 23.93 Lakhs Seized

Hyderabad: Drugs Control Administration, Telangana, has detected a significant case of fraudulent activity within the pharmaceutical industry. An investigation conducted by DCA officials has revealed that Ovoid Pharmachem Pvt. Ltd., located at Plot No. 318, Subashnagar, Quthbullapur Mandal, Medchal-Malkajgiri District, engaged in the forgery of a drug manufacturing license.

VB Kamalasan Reddy (IPS), Director General, DCA Telangana said in a press release that “Narasapally Ramudu, Director of Ovoid Pharmachem Pvt. Ltd., was involved in the creation of a forged Drug Manufacturing license in Form-25, bearing No. TS/MFG2019-43319, L.Dis.No: 315995/TS/2022 dated: 05/07/2022, for certain drug products which were not authorized for the company by the Drugs Control Administration, Telangana. This unlawful activity was carried out with the intention to deceive drug regulatory authorities, pharmaceutical manufacturers, distributors, and the public.

Upon verification of the Drugs Control Administration, Telangana licensing database on the ODLS (Online Drug Licensing System) Portal, it has been confirmed that Ovoid Pharmachem Pvt. Ltd. created a fake drug licence for certain drug products.

DCA also detected that the firm manufactured and sold certain drug products under this fraudulent license. Drugs Control Administration officials seized stocks worth Rs. 23.93 lakhs, including 800 Kgs of Activated Charcoal 250 mg and Simethicone 80 mg Pellets.”

Drugs Control Administration, Telangana, has filed a complaint with the Jeedimetla Police Station. FIR No. 327/2024 has been registered on 05-04-2024 against Mr. Narasapally Ramudu, Director of Ovoid Pharmachem Pvt. Ltd., under Sections 420 (Cheating) and 468 (Forgery) of the Indian Penal Code (IPC).

It is imperative to emphasize that the manufacturing and sale of pharmaceutical products under forged licenses pose a significant threat to public health and safety. All manufacturers shall comply strictly with regulatory requirements and maintain the highest standards of ethical conduct.

Related Posts

  • Pharma
  • May 11, 2024
  • 112 views
ICMR Urges People To Avoid Protein Supplements

New Delhi, 11 May 2024: The Indian Council of Medical Research has pressed for avoiding protein supplements for building body mass and has recommended restricting salt intake, minimising sugar and ultra-processed…

  • Pharma
  • May 11, 2024
  • 84 views
Gujarat FDCA Revokes Licenses Of Two Entities Amidst Rigorous Inspection Campaign

Mumbai: In a bid to uphold stringent regulatory standards and ensure public safety, the Gujarat Food and Drug Control Administration (FDCA) has recently embarked on a series of risk-based inspections targeting…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

ICMR Urges People To Avoid Protein Supplements

ICMR Urges People To Avoid Protein Supplements

Gujarat FDCA Revokes Licenses Of Two Entities Amidst Rigorous Inspection Campaign

Gujarat FDCA Revokes Licenses Of Two Entities Amidst Rigorous Inspection Campaign

Panipat: Wrestler And Buyer Selling Banned Drug Injections Arrested, 3500 Injections Recovered

Panipat: Wrestler And Buyer Selling Banned Drug Injections Arrested, 3500 Injections Recovered

Disclosed all rare to very rare side-effects of Covid vaccine ‘Covishield’ since ’21

Disclosed all rare to very rare side-effects of Covid vaccine ‘Covishield’ since ’21

ICMR Releases Application Form For Testing Of Vector Control Products

ICMR Releases Application Form For Testing Of Vector Control Products

Hyderabad: Youth Selling Tydol Drug Illegally Held By DCA

Hyderabad: Youth Selling Tydol Drug Illegally Held By DCA